Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia

BACKGROUND: Endothelial progenitor cell (EPC) transplantation is a promising therapy for ischemic diseases such as ischemic myocardial infarction and hindlimb ischemia. However, limitation of EPC sources remains a major obstacle. Direct reprogramming has become a powerful tool to produce EPCs from f...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Pham, Phuc, Vu, Ngoc Bich, Nguyen, Hoa Trong, Huynh, Oanh Thuy, Truong, Mai Thi-Hoang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973107/
https://www.ncbi.nlm.nih.gov/pubmed/27488544
http://dx.doi.org/10.1186/s13287-016-0368-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973107/
https://www.ncbi.nlm.nih.gov/pubmed/27488544
http://dx.doi.org/10.1186/s13287-016-0368-2

Ejemplares similares